Healthcare & Life Sciences
True North Therapeutics, Inc.
United States
True North Therapeutics, Inc. is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
series-c-plus
series-c-plus
Stage
2
Investors
About True North Therapeutics, Inc.
True North Therapeutics, Inc. is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
True North Therapeutics, Inc. develops humanized antibodies and novel biopharmaceutical therapies that inhibit the classical complement pathway to treat rare complement-mediated diseases in hematology, transplantation, and dermatology.
Explore True North Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.